Dr. Rakesh Neve

Dr. Rakesh Neve performs major interventions in the following specialities:

• Surgical Oncology

• Maharashtra Medical Council - Registration No. (81652 )

• BJ Medical College, Pune (MBBS)
• University of Pune (MS General Surgery)
• National Board of Examinations, New Delhi (DNB Surgical Oncology)
• Kyushu University, Japan (FOS)
• Anam University, Seoul, South Korea (Fellowship in Oncological Surgery)
• CICE, France (FCS)

• Gold Medal in MS

• Shukla, P. J., Neve, R., Barreto, S. G., Hawaldar, R., Nadkarni, M. S., Mohandas, K. M., & Shrikhande, S. V. (2008). A new scoring system for gallbladder cancer (aiding treatment algorithm): an analysis of 335 patients. Annals of Surgical Oncology, 15(11), 3132–3137.
• Barreto, G., Neve, R., Shrikhande, S. V., & Shukla, P. J. (2007). Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma (Br J Surg 2007; 94: 96-105). The British Journal of Surgery, 94(5), 644; author reply 644-5.
• Badwe, R. A., Parmar, V., Nair, N., Joshi, S., Hawaldar, R., Pawar, S., Kadayaprath, G., Borthakur, B. B., Rao Thammineedi, S., Pandya, S., Balasubramanian, S., Chitale, P. V., Neve, R., Harris, C., Srivastava, A., Siddique, S., Vanmali, V. J., Dewade, A., Gaikwad, V., & Gupta, S. (2023). Effect of peritumoral infiltration of local anesthetic before surgery on survival in early breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 41(18), 3318–3328.
• Nag, S., Dikshit, R., Desai, S., Mane, A., Mhatre, S., Neve, R., Gurav, M., Bhosale, N., Perumal, P., Kembhavi, Y., Jethwa, D., Badwe, R., & Gupta, S. (2023). Risk factors for the development of triple-negative breast cancer versus non-triple-negative breast cancer: a case-control study. Scientific Reports, 13(1), 13551.
• Shukla, P. J., Barreto, G., Pandey, D., Kanitkar, G., Nadkarni, M. S., Neve, R., & Shrikhande, S. V. (2007). Modification in the technique of pancreaticoduodenectomy: supracolic division of jejunum to facilitate uncinate process dissection. Hepato-Gastroenterology, 54(78), 1728–1730.
• Jain, M., Desai, S., Nagarkar, R., Neve, R., Takalkar, U., Bakhle, D., & Shah, C. (2022). Comparison of efficacy and safety of Lupin’s pegfilgrastim with Neulastim® as an adjunct to chemotherapy in patients with non myeloid malignancies: A randomised phase III clinical study. Journal of Clinical and Diagnostic Research.
• Demidov, L., Samoylenko, I., Kharkevich, G., Orlova, K., Moiseenko, V., Utyashev, I., Stroyakovskiy, D., Kozlov, V., Zimina, A., Mochalova, A., Demidova, S., Lyadova, M., Kutkovich, A., Skopin, P., Kovalenko, N., Safina, S., Volkov, V., Semiletova, Y., Vaschenko, V., … Kryukov, F. (2025). Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monotherapy in advanced cutaneous melanoma: Results from the phase III OCTAVA trial. European Journal of Cancer (Oxford, England: 1990), 227(115674), 115674.
• Shukla, P. J., Barreto, G., Neve, R., Mohandas, K. M., & Shrikhande, S. V. (2007). Can we do better than “incidental” gallbladder cancer? Hepato-Gastroenterology, 54(80), 2184–2185.

• Director - Lifepoint Multispecialty Hospital, Wakad
• Consultant - Noble Hospital and Research Centre, Pune
• Consultant - Sangvi Multispeciality Hospital, Krishna Nagar
• Director - PDEA Ayurveda Rugnalaya And Sterling Multi Speciality Hospital, Pimpri Chinchwad
• Senior Resident - Tata Memorial Hospital,Pune